XTX Topco Ltd - PDL BIOPHARMA INC ownership

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2021$0
-100.0%
18,4630.0%0.00%
-100.0%
Q2 2021$46,00018,4630.02%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
SMH CAPITAL ADVISORS INC 12,804,000$12,636,00021.66%
Context Partners Fund, L.P. 7,175,000$7,034,0004.09%
Context Capital Management, LLC 7,175,000$7,034,0004.09%
Pinnacle Holdings, LLC 3,260,000$3,217,213,0001.11%
Venator Capital Management Ltd. 2,000,000$1,960,0000.98%
LINDEN ADVISORS LP 26,617,000$26,292,0000.80%
WHITEBOX ADVISORS LLC 21,681,000$21,396,0000.65%
WOLVERINE ASSET MANAGEMENT LLC 16,852,000$16,518,0000.19%
OAKTREE CAPITAL MANAGEMENT LP 4,695,000$4,657,0000.06%
AQR Arbitrage LLC 3,150,000$3,124,0000.04%
View complete list of PDL BIOPHARMA INC shareholders